VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
STIMNeuronetics, Inc.
$1.34$93M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksSTIMBalance Sheet

Neuronetics, Inc. (STIM) Balance Sheet

10Y historyFree accessUpdated daily

The company's equity base has contracted to $13.3 million in 2026Q1 from $34.2 million in 2023Q4, reflecting a persistent erosion of shareholder value alongside an increasing reliance on debt.

STIM Balance Sheet

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16
Total Current Assets47.17M61.55M58.12M93.79M98.77M115.33M65.01M88.45M114.47M37.01M22.92M
Cash & Short-Term Investments13.21M34.36M19.66M60.58M71.88M96.34M50.84M76.59M104.58M29.15M17.04M
Cash Only13.21M34.13M19.46M59.68M70.34M94.14M48.96M75.71M104.58M29.15M17.04M
Short-Term Investments0225K206K905K1.54M2.2M1.89M880K000
Accounts Receivable16.21M16.89M24.29M17.84M13.82M7.78M7.17M6.57M5.62M4.27M3.58M
Days Sales Outstanding47.541.34118.3691.2677.3651.3453.1138.2738.8738.5238.14
Inventory4.71M4.33M4.25M8.09M8.9M6.56M3.72M2.77M2.43M2.47M1.7M
Days Inventory Outstanding21.1720.5574.8150.38209.79205.57117.5265.8271.3293.5293.48
Other Current Assets13.04M5.97M6.85M4.77M2.17M3.09M2.19M1.83M1.84M1.12M607K
Total Non-Current Assets78.27M80M82.78M22.04M18.11M25.89M13.64M11.72M2.55M1.93M1.88M
Property, Plant & Equipment26.94M28.03M33.34M4.78M5.32M5.1M4.15M4.9M1.38M1.36M1.63M
Fixed Asset Turnover5.32x5.32x2.25x14.92x12.26x10.84x11.87x12.78x38.30x29.75x21.02x
Goodwill23.62M23.62M18.63M00000000
Intangible Assets17.79M18.15M19.61M000001M400K0
Long-Term Investments775K249K86K661K1.22M1.7M2.33M1.73M000
Other Non-Current Assets9.81M9.95M11.12M16.59M11.57M19.09M7.17M5.08M171K174K250K
Total Assets125.44M141.55M140.9M115.83M116.88M141.22M78.66M100.17M117.02M38.94M24.8M
Asset Turnover1.11x1.05x0.53x0.62x0.56x0.39x0.63x0.63x0.45x1.04x1.38x
Asset Growth %124.15%0.46%21.65%-0.9%-17.23%79.54%-21.47%-14.4%200.53%57.02%-
Total Current Liabilities28.29M30.52M31.27M19.81M33.2M15.7M13.68M27.69M13.56M11.99M13.34M
Accounts Payable11.43M10.74M11.08M4.75M2.43M4.3M3.75M4.63M3.76M2.51M1.48M
Days Payables Outstanding50.2751.01195.0588.357.36134.66118.43109.7110.1495.2381.74
Short-Term Debt5.42M5.56M0013.13M0011.25M004.49M
Deferred Revenue (Current)3.23M753K974K1.62M1.98M2.5M2.02M2.23M2.25M1.97M1.33M
Other Current Liabilities10.6M13.47M8.95M8M11.2M5.09M5.02M5.72M2.64M2.72M2.37M
Current Ratio1.67x2.02x1.86x4.73x2.98x7.34x4.75x3.19x8.44x3.09x1.72x
Quick Ratio1.50x1.87x1.72x4.33x2.71x6.93x4.48x3.09x8.26x2.88x1.59x
Cash Conversion Cycle18.410.88-1.89153.34229.8122.2552.2-5.610.0436.8149.88
Total Non-Current Liabilities80.09M84.79M77.84M61.83M26.63M40.34M39.48M24.62M32.42M219.6M188.58M
Long-Term Debt18.67M65.81M55.15M59.28M22.83M35.34M34.62M19.9M30.39M29.56M15.65M
Capital Lease Obligations58.23M18.93M22.69M2.35M2.97M3.54M3.12M2.62M000
Deferred Tax Liabilities0000000000-167K
Other Non-Current Liabilities61.43M000000086K187.76M172.94M
Total Liabilities108.38M115.31M109.1M81.64M59.82M56.05M53.16M52.32M45.98M231.59M201.92M
Total Debt24.09M90.3M82.63M62.47M39.74M39.54M38.34M34.33M30.39M29.56M20.14M
Net Debt10.88M56.17M63.17M2.8M-30.59M-54.6M-10.62M-41.38M-74.19M409K3.1M
Debt / Equity1.41x3.44x2.60x1.83x0.70x0.46x1.50x0.72x0.43x--
Debt / EBITDA-0.90x----------
Net Debt / EBITDA-0.40x----------
Interest Coverage-2.43x-3.74x-5.00x-4.57x-9.34x-8.45x-5.93x-7.67x-5.53x-4.72x-5.12x
Total Equity17.06M26.24M31.8M34.19M57.06M85.17M25.49M47.85M71.04M-192.65M-177.12M
Equity Growth %222.49%-17.48%-6.99%-40.08%-33.01%234.11%-46.73%-32.64%136.88%-8.77%-
Book Value per Share0.250.401.001.192.123.341.352.607.94-17170.41-15786.45
Total Shareholders' Equity13.27M22.38M27.71M34.19M57.06M85.17M25.49M47.85M71.04M-192.65M-177.12M
Common Stock696K690K557K291K273K264K191K186K177K2K2K
Retained Earnings-469.58M-458.79M-419.79M-376.08M-345.89M-308.73M-277.54M-250.09M-221.04M-196.95M-180.89M
Treasury Stock00000000000
Accumulated OCI0000000004.23M3.71M
Minority Interest3.79M3.86M4.09M00000000

Key Metrics

Growth RegimeMixed
ProfitabilityNegative
Balance SheetVulnerable
Cash FlowBurning
Top Statement Risk

Liquidity and solvency pressure

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Deteriorating Financial Position and Solvency

According to quarterly balance sheet data, Neuronetics' equity base has contracted significantly from $34.2 million in 2023Q4 to $13.3 million in 2026Q1, reflecting a persistent erosion of shareholder value driven by ongoing operational losses and an increasing reliance on debt to fund the business.

The consistent decline in equity, coupled with a widening accumulated deficit, suggests that the company's current business model is failing to generate the internal capital necessary for self-sustainment. Investors should monitor whether this trajectory forces further dilutive equity raises or restrictive debt restructuring in the coming quarters.

Leverage Constraints and Refinancing Risk

As reported in financial filings, the company's debt-to-equity ratio has surged to 1.41 in 2026Q1 from 1.83 in 2023Q4, indicating that management is increasingly leveraging the balance sheet to offset operational cash burn while facing a shrinking equity cushion to absorb potential future losses.

The reliance on debt in a high-interest environment appears to be a necessity-driven strategy rather than a tactical capital allocation choice. This leverage profile limits financial flexibility and increases the risk of covenant breaches if the company fails to achieve its targeted revenue growth and margin expansion.

Asset Quality and Goodwill Exposure

Based on the provided balance sheet, the emergence of $23.6 million in goodwill by 2026Q1, which was previously non-existent, suggests that recent inorganic growth strategies have introduced significant intangible risk that may require future impairment testing if the acquired assets fail to meet performance expectations.

The shift toward a more asset-heavy profile, characterized by rising goodwill and fixed assets, complicates the company's liquidity position. This transition warrants further investigation into the underlying quality of these assets and whether they provide the anticipated operational synergies to justify their carrying values.

Shrinking Cash Buffer and Runway

Data from recent financial statements reveals that cash reserves have plummeted from $59.7 million in 2023Q4 to $13.2 million in 2026Q1, leaving the company with a precarious liquidity buffer that appears insufficient to support its current operating burn rate for an extended period.

The decline in the current ratio to 1.67 suggests that the company's ability to meet short-term obligations is tightening rapidly. Without a meaningful improvement in cash flow generation, the current liquidity position may necessitate external financing, which could further dilute existing shareholders or increase the interest burden.

STIM — Frequently Asked Questions

Quick answers to the most common questions about buying STIM stock.

What are the total assets of Neuronetics, Inc. (STIM)?

As of 2025, Neuronetics, Inc. (STIM) had total assets of $141.6M including $61.6M in current assets.

How much debt does Neuronetics, Inc. (STIM) have?

Neuronetics, Inc. (STIM) carries total debt of $90.3M, offset by $34.4M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.

What is the book value or shareholders' equity of Neuronetics, Inc.?

Neuronetics, Inc. (STIM) has total shareholders' equity (book value) of $22.4M ($0.40 book value per share). Book value represents the net worth of the company belonging to common stock holders.

What is Neuronetics, Inc.'s current ratio and liquidity?

Neuronetics, Inc. (STIM) reported a current ratio of 2.02x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.